The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Taxane Antineoplastic Drug Market Research Report 2024
Synopsis
Taxane antitumor drugs are a type of widely used chemotherapy drugs, mainly used to treat a variety of cancers, including breast cancer, ovarian cancer, lung cancer, esophageal cancer, bladder cancer, and head and neck cancer.
The global Taxane Antineoplastic Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The main mechanism of action of taxane antitumor drugs is to interfere with the mitosis process of tumor cells, thereby preventing the proliferation and spread of tumor cells.
This report aims to provide a comprehensive presentation of the global market for Taxane Antineoplastic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Taxane Antineoplastic Drug.
Report Scope
The Taxane Antineoplastic Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Taxane Antineoplastic Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Taxane Antineoplastic Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Sanofi US
Sun Pharma
Oasmia
Indena
Bristol-Myers Squibb Company
Qilu Pharmaceutical
Fuxing Medicine
Yuekang Pharmaceutical
Hengrui Medicine
Huiyu Pharmaceutical
Zhendong Pharmaceutical
Segment by Type
Paclitaxel
Docetaxel
Cabazitaxel
Others
Segment by Application
Breast Cancer
Stomach Cancer
Ovarian Cancer
Lung Cancer
Testicular Cancer
Cervical Cancer
Endometrial Cancer
Prostate Cancer
Bladder Cancer
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Taxane Antineoplastic Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Taxane Antineoplastic Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Taxane antitumor drugs are a type of widely used chemotherapy drugs, mainly used to treat a variety of cancers, including breast cancer, ovarian cancer, lung cancer, esophageal cancer, bladder cancer, and head and neck cancer.
The global Taxane Antineoplastic Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The main mechanism of action of taxane antitumor drugs is to interfere with the mitosis process of tumor cells, thereby preventing the proliferation and spread of tumor cells.
This report aims to provide a comprehensive presentation of the global market for Taxane Antineoplastic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Taxane Antineoplastic Drug.
Report Scope
The Taxane Antineoplastic Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Taxane Antineoplastic Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Taxane Antineoplastic Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Sanofi US
Sun Pharma
Oasmia
Indena
Bristol-Myers Squibb Company
Qilu Pharmaceutical
Fuxing Medicine
Yuekang Pharmaceutical
Hengrui Medicine
Huiyu Pharmaceutical
Zhendong Pharmaceutical
Segment by Type
Paclitaxel
Docetaxel
Cabazitaxel
Others
Segment by Application
Breast Cancer
Stomach Cancer
Ovarian Cancer
Lung Cancer
Testicular Cancer
Cervical Cancer
Endometrial Cancer
Prostate Cancer
Bladder Cancer
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Taxane Antineoplastic Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Taxane Antineoplastic Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Taxane Antineoplastic Drug Market Overview
1.1 Product Overview and Scope of Taxane Antineoplastic Drug
1.2 Taxane Antineoplastic Drug Segment by Type
1.2.1 Global Taxane Antineoplastic Drug Market Value Comparison by Type (2024-2030)
1.2.2 Paclitaxel
1.2.3 Docetaxel
1.2.4 Cabazitaxel
1.2.5 Others
1.3 Taxane Antineoplastic Drug Segment by Application
1.3.1 Global Taxane Antineoplastic Drug Market Value by Application: (2024-2030)
1.3.2 Breast Cancer
1.3.3 Stomach Cancer
1.3.4 Ovarian Cancer
1.3.5 Lung Cancer
1.3.6 Testicular Cancer
1.3.7 Cervical Cancer
1.3.8 Endometrial Cancer
1.3.9 Prostate Cancer
1.3.10 Bladder Cancer
1.3.11 Others
1.4 Global Taxane Antineoplastic Drug Market Size Estimates and Forecasts
1.4.1 Global Taxane Antineoplastic Drug Revenue 2019-2030
1.4.2 Global Taxane Antineoplastic Drug Sales 2019-2030
1.4.3 Global Taxane Antineoplastic Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Taxane Antineoplastic Drug Market Competition by Manufacturers
2.1 Global Taxane Antineoplastic Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Taxane Antineoplastic Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Taxane Antineoplastic Drug Average Price by Manufacturers (2019-2024)
2.4 Global Taxane Antineoplastic Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Taxane Antineoplastic Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Taxane Antineoplastic Drug, Product Type & Application
2.7 Taxane Antineoplastic Drug Market Competitive Situation and Trends
2.7.1 Taxane Antineoplastic Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Taxane Antineoplastic Drug Players Market Share by Revenue
2.7.3 Global Taxane Antineoplastic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Taxane Antineoplastic Drug Retrospective Market Scenario by Region
3.1 Global Taxane Antineoplastic Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Taxane Antineoplastic Drug Global Taxane Antineoplastic Drug Sales by Region: 2019-2030
3.2.1 Global Taxane Antineoplastic Drug Sales by Region: 2019-2024
3.2.2 Global Taxane Antineoplastic Drug Sales by Region: 2025-2030
3.3 Global Taxane Antineoplastic Drug Global Taxane Antineoplastic Drug Revenue by Region: 2019-2030
3.3.1 Global Taxane Antineoplastic Drug Revenue by Region: 2019-2024
3.3.2 Global Taxane Antineoplastic Drug Revenue by Region: 2025-2030
3.4 North America Taxane Antineoplastic Drug Market Facts & Figures by Country
3.4.1 North America Taxane Antineoplastic Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Taxane Antineoplastic Drug Sales by Country (2019-2030)
3.4.3 North America Taxane Antineoplastic Drug Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Taxane Antineoplastic Drug Market Facts & Figures by Country
3.5.1 Europe Taxane Antineoplastic Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Taxane Antineoplastic Drug Sales by Country (2019-2030)
3.5.3 Europe Taxane Antineoplastic Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Taxane Antineoplastic Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Taxane Antineoplastic Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Taxane Antineoplastic Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Taxane Antineoplastic Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Taxane Antineoplastic Drug Market Facts & Figures by Country
3.7.1 Latin America Taxane Antineoplastic Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Taxane Antineoplastic Drug Sales by Country (2019-2030)
3.7.3 Latin America Taxane Antineoplastic Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Taxane Antineoplastic Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Taxane Antineoplastic Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Taxane Antineoplastic Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Taxane Antineoplastic Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Taxane Antineoplastic Drug Sales by Type (2019-2030)
4.1.1 Global Taxane Antineoplastic Drug Sales by Type (2019-2024)
4.1.2 Global Taxane Antineoplastic Drug Sales by Type (2025-2030)
4.1.3 Global Taxane Antineoplastic Drug Sales Market Share by Type (2019-2030)
4.2 Global Taxane Antineoplastic Drug Revenue by Type (2019-2030)
4.2.1 Global Taxane Antineoplastic Drug Revenue by Type (2019-2024)
4.2.2 Global Taxane Antineoplastic Drug Revenue by Type (2025-2030)
4.2.3 Global Taxane Antineoplastic Drug Revenue Market Share by Type (2019-2030)
4.3 Global Taxane Antineoplastic Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Taxane Antineoplastic Drug Sales by Application (2019-2030)
5.1.1 Global Taxane Antineoplastic Drug Sales by Application (2019-2024)
5.1.2 Global Taxane Antineoplastic Drug Sales by Application (2025-2030)
5.1.3 Global Taxane Antineoplastic Drug Sales Market Share by Application (2019-2030)
5.2 Global Taxane Antineoplastic Drug Revenue by Application (2019-2030)
5.2.1 Global Taxane Antineoplastic Drug Revenue by Application (2019-2024)
5.2.2 Global Taxane Antineoplastic Drug Revenue by Application (2025-2030)
5.2.3 Global Taxane Antineoplastic Drug Revenue Market Share by Application (2019-2030)
5.3 Global Taxane Antineoplastic Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Taxane Antineoplastic Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Taxane Antineoplastic Drug Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Sanofi US
6.2.1 Sanofi US Corporation Information
6.2.2 Sanofi US Description and Business Overview
6.2.3 Sanofi US Taxane Antineoplastic Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi US Taxane Antineoplastic Drug Product Portfolio
6.2.5 Sanofi US Recent Developments/Updates
6.3 Sun Pharma
6.3.1 Sun Pharma Corporation Information
6.3.2 Sun Pharma Description and Business Overview
6.3.3 Sun Pharma Taxane Antineoplastic Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sun Pharma Taxane Antineoplastic Drug Product Portfolio
6.3.5 Sun Pharma Recent Developments/Updates
6.4 Oasmia
6.4.1 Oasmia Corporation Information
6.4.2 Oasmia Description and Business Overview
6.4.3 Oasmia Taxane Antineoplastic Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Oasmia Taxane Antineoplastic Drug Product Portfolio
6.4.5 Oasmia Recent Developments/Updates
6.5 Indena
6.5.1 Indena Corporation Information
6.5.2 Indena Description and Business Overview
6.5.3 Indena Taxane Antineoplastic Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Indena Taxane Antineoplastic Drug Product Portfolio
6.5.5 Indena Recent Developments/Updates
6.6 Bristol-Myers Squibb Company
6.6.1 Bristol-Myers Squibb Company Corporation Information
6.6.2 Bristol-Myers Squibb Company Description and Business Overview
6.6.3 Bristol-Myers Squibb Company Taxane Antineoplastic Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bristol-Myers Squibb Company Taxane Antineoplastic Drug Product Portfolio
6.6.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.7 Qilu Pharmaceutical
6.6.1 Qilu Pharmaceutical Corporation Information
6.6.2 Qilu Pharmaceutical Description and Business Overview
6.6.3 Qilu Pharmaceutical Taxane Antineoplastic Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Qilu Pharmaceutical Taxane Antineoplastic Drug Product Portfolio
6.7.5 Qilu Pharmaceutical Recent Developments/Updates
6.8 Fuxing Medicine
6.8.1 Fuxing Medicine Corporation Information
6.8.2 Fuxing Medicine Description and Business Overview
6.8.3 Fuxing Medicine Taxane Antineoplastic Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Fuxing Medicine Taxane Antineoplastic Drug Product Portfolio
6.8.5 Fuxing Medicine Recent Developments/Updates
6.9 Yuekang Pharmaceutical
6.9.1 Yuekang Pharmaceutical Corporation Information
6.9.2 Yuekang Pharmaceutical Description and Business Overview
6.9.3 Yuekang Pharmaceutical Taxane Antineoplastic Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Yuekang Pharmaceutical Taxane Antineoplastic Drug Product Portfolio
6.9.5 Yuekang Pharmaceutical Recent Developments/Updates
6.10 Hengrui Medicine
6.10.1 Hengrui Medicine Corporation Information
6.10.2 Hengrui Medicine Description and Business Overview
6.10.3 Hengrui Medicine Taxane Antineoplastic Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hengrui Medicine Taxane Antineoplastic Drug Product Portfolio
6.10.5 Hengrui Medicine Recent Developments/Updates
6.11 Huiyu Pharmaceutical
6.11.1 Huiyu Pharmaceutical Corporation Information
6.11.2 Huiyu Pharmaceutical Taxane Antineoplastic Drug Description and Business Overview
6.11.3 Huiyu Pharmaceutical Taxane Antineoplastic Drug Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Huiyu Pharmaceutical Taxane Antineoplastic Drug Product Portfolio
6.11.5 Huiyu Pharmaceutical Recent Developments/Updates
6.12 Zhendong Pharmaceutical
6.12.1 Zhendong Pharmaceutical Corporation Information
6.12.2 Zhendong Pharmaceutical Taxane Antineoplastic Drug Description and Business Overview
6.12.3 Zhendong Pharmaceutical Taxane Antineoplastic Drug Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Zhendong Pharmaceutical Taxane Antineoplastic Drug Product Portfolio
6.12.5 Zhendong Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Taxane Antineoplastic Drug Industry Chain Analysis
7.2 Taxane Antineoplastic Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Taxane Antineoplastic Drug Production Mode & Process
7.4 Taxane Antineoplastic Drug Sales and Marketing
7.4.1 Taxane Antineoplastic Drug Sales Channels
7.4.2 Taxane Antineoplastic Drug Distributors
7.5 Taxane Antineoplastic Drug Customers
8 Taxane Antineoplastic Drug Market Dynamics
8.1 Taxane Antineoplastic Drug Industry Trends
8.2 Taxane Antineoplastic Drug Market Drivers
8.3 Taxane Antineoplastic Drug Market Challenges
8.4 Taxane Antineoplastic Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Taxane Antineoplastic Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Taxane Antineoplastic Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Taxane Antineoplastic Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Taxane Antineoplastic Drug Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Taxane Antineoplastic Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Taxane Antineoplastic Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Taxane Antineoplastic Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Taxane Antineoplastic Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Taxane Antineoplastic Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Taxane Antineoplastic Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Taxane Antineoplastic Drug, Product Type & Application
Table 12. Global Key Manufacturers of Taxane Antineoplastic Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Taxane Antineoplastic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Taxane Antineoplastic Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Taxane Antineoplastic Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Taxane Antineoplastic Drug Sales by Region (2019-2024) & (K Units)
Table 18. Global Taxane Antineoplastic Drug Sales Market Share by Region (2019-2024)
Table 19. Global Taxane Antineoplastic Drug Sales by Region (2025-2030) & (K Units)
Table 20. Global Taxane Antineoplastic Drug Sales Market Share by Region (2025-2030)
Table 21. Global Taxane Antineoplastic Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Taxane Antineoplastic Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Taxane Antineoplastic Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Taxane Antineoplastic Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Taxane Antineoplastic Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Taxane Antineoplastic Drug Sales by Country (2019-2024) & (K Units)
Table 27. North America Taxane Antineoplastic Drug Sales by Country (2025-2030) & (K Units)
Table 28. North America Taxane Antineoplastic Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Taxane Antineoplastic Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Taxane Antineoplastic Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Taxane Antineoplastic Drug Sales by Country (2019-2024) & (K Units)
Table 32. Europe Taxane Antineoplastic Drug Sales by Country (2025-2030) & (K Units)
Table 33. Europe Taxane Antineoplastic Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Taxane Antineoplastic Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Taxane Antineoplastic Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Taxane Antineoplastic Drug Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Taxane Antineoplastic Drug Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Taxane Antineoplastic Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Taxane Antineoplastic Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Taxane Antineoplastic Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Taxane Antineoplastic Drug Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Taxane Antineoplastic Drug Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Taxane Antineoplastic Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Taxane Antineoplastic Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Taxane Antineoplastic Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Taxane Antineoplastic Drug Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Taxane Antineoplastic Drug Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Taxane Antineoplastic Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Taxane Antineoplastic Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Taxane Antineoplastic Drug Sales (K Units) by Type (2019-2024)
Table 51. Global Taxane Antineoplastic Drug Sales (K Units) by Type (2025-2030)
Table 52. Global Taxane Antineoplastic Drug Sales Market Share by Type (2019-2024)
Table 53. Global Taxane Antineoplastic Drug Sales Market Share by Type (2025-2030)
Table 54. Global Taxane Antineoplastic Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Taxane Antineoplastic Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Taxane Antineoplastic Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Taxane Antineoplastic Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Taxane Antineoplastic Drug Price (US$/Unit) by Type (2019-2024)
Table 59. Global Taxane Antineoplastic Drug Price (US$/Unit) by Type (2025-2030)
Table 60. Global Taxane Antineoplastic Drug Sales (K Units) by Application (2019-2024)
Table 61. Global Taxane Antineoplastic Drug Sales (K Units) by Application (2025-2030)
Table 62. Global Taxane Antineoplastic Drug Sales Market Share by Application (2019-2024)
Table 63. Global Taxane Antineoplastic Drug Sales Market Share by Application (2025-2030)
Table 64. Global Taxane Antineoplastic Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Taxane Antineoplastic Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Taxane Antineoplastic Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Taxane Antineoplastic Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Taxane Antineoplastic Drug Price (US$/Unit) by Application (2019-2024)
Table 69. Global Taxane Antineoplastic Drug Price (US$/Unit) by Application (2025-2030)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Taxane Antineoplastic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer Taxane Antineoplastic Drug Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Sanofi US Corporation Information
Table 76. Sanofi US Description and Business Overview
Table 77. Sanofi US Taxane Antineoplastic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Sanofi US Taxane Antineoplastic Drug Product
Table 79. Sanofi US Recent Developments/Updates
Table 80. Sun Pharma Corporation Information
Table 81. Sun Pharma Description and Business Overview
Table 82. Sun Pharma Taxane Antineoplastic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Sun Pharma Taxane Antineoplastic Drug Product
Table 84. Sun Pharma Recent Developments/Updates
Table 85. Oasmia Corporation Information
Table 86. Oasmia Description and Business Overview
Table 87. Oasmia Taxane Antineoplastic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Oasmia Taxane Antineoplastic Drug Product
Table 89. Oasmia Recent Developments/Updates
Table 90. Indena Corporation Information
Table 91. Indena Description and Business Overview
Table 92. Indena Taxane Antineoplastic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Indena Taxane Antineoplastic Drug Product
Table 94. Indena Recent Developments/Updates
Table 95. Bristol-Myers Squibb Company Corporation Information
Table 96. Bristol-Myers Squibb Company Description and Business Overview
Table 97. Bristol-Myers Squibb Company Taxane Antineoplastic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Bristol-Myers Squibb Company Taxane Antineoplastic Drug Product
Table 99. Bristol-Myers Squibb Company Recent Developments/Updates
Table 100. Qilu Pharmaceutical Corporation Information
Table 101. Qilu Pharmaceutical Description and Business Overview
Table 102. Qilu Pharmaceutical Taxane Antineoplastic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Qilu Pharmaceutical Taxane Antineoplastic Drug Product
Table 104. Qilu Pharmaceutical Recent Developments/Updates
Table 105. Fuxing Medicine Corporation Information
Table 106. Fuxing Medicine Description and Business Overview
Table 107. Fuxing Medicine Taxane Antineoplastic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Fuxing Medicine Taxane Antineoplastic Drug Product
Table 109. Fuxing Medicine Recent Developments/Updates
Table 110. Yuekang Pharmaceutical Corporation Information
Table 111. Yuekang Pharmaceutical Description and Business Overview
Table 112. Yuekang Pharmaceutical Taxane Antineoplastic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Yuekang Pharmaceutical Taxane Antineoplastic Drug Product
Table 114. Yuekang Pharmaceutical Recent Developments/Updates
Table 115. Hengrui Medicine Corporation Information
Table 116. Hengrui Medicine Description and Business Overview
Table 117. Hengrui Medicine Taxane Antineoplastic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Hengrui Medicine Taxane Antineoplastic Drug Product
Table 119. Hengrui Medicine Recent Developments/Updates
Table 120. Huiyu Pharmaceutical Corporation Information
Table 121. Huiyu Pharmaceutical Description and Business Overview
Table 122. Huiyu Pharmaceutical Taxane Antineoplastic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Huiyu Pharmaceutical Taxane Antineoplastic Drug Product
Table 124. Huiyu Pharmaceutical Recent Developments/Updates
Table 125. Zhendong Pharmaceutical Corporation Information
Table 126. Zhendong Pharmaceutical Description and Business Overview
Table 127. Zhendong Pharmaceutical Taxane Antineoplastic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Zhendong Pharmaceutical Taxane Antineoplastic Drug Product
Table 129. Zhendong Pharmaceutical Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Taxane Antineoplastic Drug Distributors List
Table 133. Taxane Antineoplastic Drug Customers List
Table 134. Taxane Antineoplastic Drug Market Trends
Table 135. Taxane Antineoplastic Drug Market Drivers
Table 136. Taxane Antineoplastic Drug Market Challenges
Table 137. Taxane Antineoplastic Drug Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Taxane Antineoplastic Drug
Figure 2. Global Taxane Antineoplastic Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Taxane Antineoplastic Drug Market Share by Type in 2023 & 2030
Figure 4. Paclitaxel Product Picture
Figure 5. Docetaxel Product Picture
Figure 6. Cabazitaxel Product Picture
Figure 7. Others Product Picture
Figure 8. Global Taxane Antineoplastic Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Taxane Antineoplastic Drug Market Share by Application in 2023 & 2030
Figure 10. Breast Cancer
Figure 11. Stomach Cancer
Figure 12. Ovarian Cancer
Figure 13. Lung Cancer
Figure 14. Testicular Cancer
Figure 15. Cervical Cancer
Figure 16. Endometrial Cancer
Figure 17. Prostate Cancer
Figure 18. Bladder Cancer
Figure 19. Others
Figure 20. Global Taxane Antineoplastic Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 21. Global Taxane Antineoplastic Drug Market Size (2019-2030) & (US$ Million)
Figure 22. Global Taxane Antineoplastic Drug Sales (2019-2030) & (K Units)
Figure 23. Global Taxane Antineoplastic Drug Average Price (US$/Unit) & (2019-2030)
Figure 24. Taxane Antineoplastic Drug Report Years Considered
Figure 25. Taxane Antineoplastic Drug Sales Share by Manufacturers in 2023
Figure 26. Global Taxane Antineoplastic Drug Revenue Share by Manufacturers in 2023
Figure 27. The Global 5 and 10 Largest Taxane Antineoplastic Drug Players: Market Share by Revenue in 2023
Figure 28. Taxane Antineoplastic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 29. Global Taxane Antineoplastic Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 30. North America Taxane Antineoplastic Drug Sales Market Share by Country (2019-2030)
Figure 31. North America Taxane Antineoplastic Drug Revenue Market Share by Country (2019-2030)
Figure 32. United States Taxane Antineoplastic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Canada Taxane Antineoplastic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Europe Taxane Antineoplastic Drug Sales Market Share by Country (2019-2030)
Figure 35. Europe Taxane Antineoplastic Drug Revenue Market Share by Country (2019-2030)
Figure 36. Germany Taxane Antineoplastic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. France Taxane Antineoplastic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. U.K. Taxane Antineoplastic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Italy Taxane Antineoplastic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Netherlands Taxane Antineoplastic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Asia Pacific Taxane Antineoplastic Drug Sales Market Share by Region (2019-2030)
Figure 42. Asia Pacific Taxane Antineoplastic Drug Revenue Market Share by Region (2019-2030)
Figure 43. China Taxane Antineoplastic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Japan Taxane Antineoplastic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. South Korea Taxane Antineoplastic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. India Taxane Antineoplastic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Taxane Antineoplastic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. China Taiwan Taxane Antineoplastic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Australia Taxane Antineoplastic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Latin America Taxane Antineoplastic Drug Sales Market Share by Country (2019-2030)
Figure 51. Latin America Taxane Antineoplastic Drug Revenue Market Share by Country (2019-2030)
Figure 52. Mexico Taxane Antineoplastic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Brazil Taxane Antineoplastic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Argentina Taxane Antineoplastic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Colombia Taxane Antineoplastic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Middle East & Africa Taxane Antineoplastic Drug Sales Market Share by Country (2019-2030)
Figure 57. Middle East & Africa Taxane Antineoplastic Drug Revenue Market Share by Country (2019-2030)
Figure 58. Turkey Taxane Antineoplastic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 59. Saudi Arabia Taxane Antineoplastic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 60. UAE Taxane Antineoplastic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 61. Global Sales Market Share of Taxane Antineoplastic Drug by Type (2019-2030)
Figure 62. Global Revenue Market Share of Taxane Antineoplastic Drug by Type (2019-2030)
Figure 63. Global Taxane Antineoplastic Drug Price (US$/Unit) by Type (2019-2030)
Figure 64. Global Sales Market Share of Taxane Antineoplastic Drug by Application (2019-2030)
Figure 65. Global Revenue Market Share of Taxane Antineoplastic Drug by Application (2019-2030)
Figure 66. Global Taxane Antineoplastic Drug Price (US$/Unit) by Application (2019-2030)
Figure 67. Taxane Antineoplastic Drug Value Chain
Figure 68. Taxane Antineoplastic Drug Production Process
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Distributors Profiles
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
